G60.1
Refsum's disease
Clinical Classification Guidelines
Inclusion Terms
- Infantile Refsum disease
Medical Intelligence & Overview
Refsum's disease, specifically infantile Refsum disease under ICD-10 code G60.1, is a rare genetic disorder that affects the nervous system and various other parts of the body. It is characterized by the abnormal accumulation of phytanic acid, a type of fat found in certain foods, leading to a wide range of health issues. Originating from inherited metabolic errors, Refsum's disease can significantly impact quality of life if not managed properly. This condition is divided into different types based on age of onset and severity, with infantile Refsum disease presenting earlier in life.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting enzymes involved in the breakdown of phytanic acid Inheritance in an autosomal recessive pattern, requiring both parents to carry the gene mutation Deficiency in phytanoyl-CoA hydroxylase, an enzyme crucial for phytanic acid metabolism Lack of effective processing of phytanic acid leading to its buildup in tissues Family history of similar metabolic disorders
Key Symptoms: Delayed developmental milestones in infants Hypotonia (reduced muscle tone) Retinal degeneration leading to vision problems or blindness Sensorineural hearing loss Ichthyosis, a scaly skin condition Cardiac abnormalities such as arrhythmias Peripheral neuropathy causing numbness or tingling Facial features including a prominent forehead and a broad nasal bridge Growth delays and failure to thrive Seizures and other neurological issues
Diagnostic & Treatment
Diagnosis Path: Diagnosis of infantile Refsum disease involves a combination of clinical evaluation and laboratory tests. Key diagnostic steps include: - Blood tests to measure phytanic acid levels, which are typically elevated - Genetic testing to identify mutations in the PHYH gene or other related genes - Ophthalmologic examination to assess retinal health - Hearing assessments to evaluate for sensorineural loss - Imaging studies like MRI to examine brain and nerve health - Skin biopsies may be utilized to evaluate skin abnormalities Early diagnosis is critical to manage symptoms effectively and prevent severe complications.
Treatment Protocols: Management of Refsum's disease focuses on reducing phytanic acid levels to prevent or slow the progression of symptoms. Common approaches include: - Dietary restrictions limiting intake of foods rich in phytanic acid, such as dairy products, beef, lamb, and certain fish - Regular monitoring of phytanic acid levels to assess treatment efficacy - Use of plasmapheresis or lipid apheresis in some cases to remove excess phytanic acid from the blood - Supportive therapies aimed at managing specific symptoms: - Visual aids and interventions for retinal degeneration - Hearing aids or cochlear implants for hearing loss - Physical and occupational therapy for motor skills and development - Cardiac management for heart rhythm abnormalities - Genetic counseling for affected families to understand inheritance patterns and risks Ongoing medical supervision is essential to manage symptoms and adapt treatment plans as needed.
Clinical Advice & FAQs
Billing Guidance
Is G60.1 a billable ICD-10 code?
Yes, G60.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G60.1?
Clinical documentation must specify the nature of Refsum's disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
